Antiviral besifovir may be a safer alternative for long-term hepatitis B treatment
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
pharmaphorum8d
Hepatitis drug wins award for cure rate and efficacy
Hepatitis C drug Ganovo won a top clinical ... Non-cirrhotic patients on a treatment regimen of Ganovo, which is produced by Chinese biotech company, Ascletis, demonstrated a cure rate of 97% ...
Exploring Unmet Needs In Chronic Hepatitis B: Understanding The Disease, Its Impact And The Potential Of Functional Cure
While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
EurekAlert!13d
New study by Korea University researchers reveals a safer alternative for long-term hepatitis B treatment
Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil ...
Daily Post Nigeria13d
Increase funding for hepatitis treatment – Stakeholders urge govt
Concerned stakeholders in Taraba State have collectively called on the government at all levels to increase funding for viral ...